Skye Bioscience Inc (SKYE) Implied Volatility Current

Tracking SKYE implied volatility helps you identify when options premiums on Skye Bioscience Inc are historically cheap or expensive, and where the best trades are hiding. Skye Bioscience Inc implied volatility reflects the market's expectation of future price movement: when SKYE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Skye Bioscience Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For SKYE, tracking metrics like SKYE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on SKYE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc.

was founded in 2012 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where SKYE implied volatility sits today versus where it has been. Our scanner ranks Skye Bioscience Inc implied volatility against its historical range, surfaces extremes in SKYE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Skye Bioscience Inc IV is rich or cheap — measure it, then act on it.